HDFC Bank’s first-half 2014 earnings were up 29% on the prior comparable period, with pretax, pre-provision earnings up 27%. These results exceeded expectations, with growth in provisions and operating expenses (up 4% and 17%, respectively) significantly trailing the 22% growth in net revenues. However, this divergence between income and cost growth is not unusual given…
Google Inc (NASDAQ GOOG)’s earnings results disappointed last week, or more specifically, one particular metric disappointed. Growth in paid clicks decelerated in the quarter, leaving investors with worries about Google’s near term growth. However, BGC analysts believe Wall Street is focusing on the wrong metric. They think growth in cost per click is more important…
Facebook Inc (NASDAQ FB) is mad at the United States Drug Enforcement Administration for creating fake accounts to catch drug offenders. The social media giant sent a formal complaint to the DEA. Facebook recently sent a letter to the DEA asking them to stop impersonating users. The letter comes from Joe Sullivan (Facebook’s security chief…
Nike chief executive Mark Parker has hinted at a future collaboration with Apple on a new item of wearable technology, which will be more “stealth” than existing products. Since 2006 the two companies have partnered on wearable technology, with their first attempt marked by the Nike+ running which was released in 2006 and connected wirelessly…
Real Madrid vs Barcelona Live Stream: watch one of the most hotly anticipated fixtures of the European football season as European Cup holders, Real Madrid, host their historic rivals in the opening Classico of the new La Liga campaign. Real and Barca fans can watch the big match live on TV or on the internet via…
Pharmacyclics (PCYC) announced that it has teamed up with Roche (RHHBY) for evaluating the safety, tolerability and preliminary efficacy of its oncology treatment, Imbruvica, in combination with the latter’s Gazyva. The companies will assess the cocktail therapy in patients with non-hodgkin lymphoma (NHL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in multiple clinical trials. As…
Tech Analysis & Market News